Expert Opinion on Pharmacotherapy

Preventing cardiovascular and renal complications in the management of hypertension and metabolic syndrome
pp. 2001-2009(9)
Authors: Chen, Jing; Townsend, Raymond R

Effect of buccal dwell time on the pharmacokinetic profile of fentanyl buccal tablet
pp. 2011-2016(6)
Authors: Darwish, M; Kirby, M; Jiang, JG

Immediate removal of femoral-sheath following protamine administration in patients undergoing intracoronary paclitaxel-eluting-stent implantation
pp. 2017-2024(8)
Authors: Rossi, Marco L; Zavalloni, Dennis; Scatturin, Melania; Gasparini, Gabriele L; Lisignoli, Veronica; Presbitero, Patrizia

The prevalence of pantoprozole associated thrombocytopenia in a community hospital
pp. 2025-2028(4)
Authors: Dotan, Efrat; Katz, Randi; Bratcher, Jason; Wasserman, Carrie; Liebman, Michelene; Panagopoulos, Georgia; Spaccavento, Colette

Eating disorders: an overview of treatment responses and the potential impact of vulnerability genes and endophenotypes
pp. 2029-2044(16)
Authors: Ramoz, Nicolas; Versini, Audrey; Gorwood, Philip

Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantation
pp. 2045-2058(14)
Authors: NG, Fu Liang; Holt, David W; MacPhee, Iain AM

Metabolic syndrome management
pp. 2059-2075(17)
Authors: Stone, Neil J; Schmeltz, Lowell R

Non-corticosteroid therapy for the long-term control of asthma
pp. 2077-2087(11)
Author: Kelly, H William

The use of TNF-α blocking agents in rheumatoid arthritis: an update
pp. 2089-2107(19)
Authors: Toussirot, Éric; Wendling, Daniel

Targeting polyamine metabolism: a viable therapeutic/preventative solution for cancer?
pp. 2109-2116(8)
Author: Wallace, Heather M

Venous thromboembolism prevention in cancer patients: the search for common antecedents
pp. 2117-2125(9)
Authors: Zacharski, Leo R; Engman, Cocav A

Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release)
pp. 2127-2134(8)
Author: Faraone, Stephen V

Combined use of ultra-short acting β-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone
pp. 2135-2147(13)
Authors: Boldt, Joachim; Suttner, Stephan

Ranolazine in patients with coronary artery disease
pp. 2149-2157(9)
Author: Scirica, Benjamin M

Simvastatin: present and future perspectives
pp. 2159-2127(-31)
Author: Robinson, Jennifer G

Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction
pp. 2173-2187(15)
Author: Storms, William

Lapatinib: a tyrosine kinase inhibitor with a clinical role in breast cancer
pp. 2189-2204(16)
Authors: Mukherjee, A; Dhadda, AS; Shehata, M; Chan, Stephen